(S (NP-SBJ-38 Epstein-Barr/JJ viral/JJ latency/NN) (VP is/VBZ (VP disrupted/VBN (NP *-38/-NONE-) (PP by/IN (NP-LGS the/DT immediate-early/JJ BRLF1/NN protein/NN)) (PP through/IN (NP a/DT cell-specific/JJ mechanism/NN)))) ./.)
(S (NP-SBJ (NP (NP Epstein-Barr/JJ virus/NN) (PRN -LRB-/-LRB- (NP EBV/NN) -RRB-/-RRB-)) ,/, (NP (NP the/DT causative/JJ agent/NN) (PP of/IN (NP infectious/JJ mononucleosis/NN))) ,/,) (VP is/VBZ (NP-PRD (NP a/DT human/JJ herpesvirus/NN) (VP associated/VBN (NP */-NONE-) (PP with/IN (NP-COOD (NP (NP epithelial/JJ cell/NN malignancies/NNS) (PRN -LRB-/-LRB- (NP nasopharyngeal/JJ carcinoma/NN) -RRB-/-RRB-)) (CONJP as/RB well/RB as/IN) (NP B-cell/NN malignancies/NNS)))))) ./.)
(S (S-SBJ (NP-SBJ */-NONE-) (VP Understanding/VBG (SBAR (WHADVP-39 how/WRB) (S (NP-SBJ-40 viral/JJ latency/NN) (VP is/VBZ (VP disrupted/VBN (NP *-40/-NONE-) (ADVP *T*-39/-NONE-))))))) (VP is/VBZ (NP-PRD (NP a/DT central/JJ issue/NN) (PP in/IN (NP herpesvirus/JJ biology/NN)))) ./.)
(S-COOD (S (NP-SBJ Epithelial/JJ cells/NNS) (VP are/VBP (NP-PRD (NP the/DT major/JJ site/NN) (PP of/IN (NP (NP lytic/JJ EBV/NN replication/NN) (PP within/IN (NP the/DT human/JJ host/NN))))))) ,/, and/CC (S (NP-SBJ viral/JJ reactivation/NN) (VP occurs/VBZ (PP in/IN (NP EBV-associated/JJ nasopharyngeal/JJ carcinomas/NNS)))) ./.)
(S (NP-SBJ It/PRP) (VP is/VBZ (VP known/VBN (SBAR that/IN (S (NP-SBJ (NP expression/NN) (PP of/IN (NP (NP a/DT single/JJ viral/JJ immediate-early/JJ protein/NN) ,/, (NP BZLF1/NN) ,/,))) (VP is/VBZ (ADJP-PRD sufficient/JJ (S (NP-SBJ */-NONE-) (VP to/TO (VP initiate/VB (NP (NP the/DT switch/NN) (PP from/IN (NP latent/JJ (NP *RNR*-41/-NONE-))) (PP to/TO (NP lytic/JJ (NP *RNR*-41/-NONE-))) (NP-41 infection/NN) (PP in/IN (NP B/NN cells/NNS)))))))))))) ./.)
(S (NP-SBJ-42 (NP Cellular/JJ regulation/NN) (PP of/IN (NP BZLF1/NN transcription/NN))) (VP is/VBZ (ADVP therefore/RB) (VP thought/VBN (S (NP-SBJ-43 *-42/-NONE-) (VP to/TO (VP play/VB (NP a/DT key/JJ role/NN) (PP in/IN (S (NP-SBJ *-43/-NONE-) (VP regulating/VBG (NP (NP the/DT stringency/NN) (PP of/IN (NP viral/JJ latency/NN))))))))))) ./.)
(S (ADVP Here/RB) (NP-SBJ we/PRP) (VP show/VBP (SBAR that/IN ,/, (S (ADVP unexpectedly/RB) ,/, (NP-SBJ (NP expression/NN) (PP of/IN (NP (NP another/DT viral/JJ immediate-early/JJ protein/NN) ,/, (NP BRLF1/NN) ,/,))) (VP can/MD (VP disrupt/VB (NP viral/JJ latency/NN) (PP in/IN (NP an/DT (ADJP epithelial/JJ cell-specific/JJ) fashion/NN))))))) ./.)
(S (ADVP Therefore/RB) ,/, (NP-SBJ-44 (NP the/DT mechanisms/NNS) (VP leading/VBG (PP to/TO (NP (NP disruption/NN) (PP of/IN (NP EBV/NN latency/NN)))))) (VP appear/VBP (S (NP-SBJ *-44/-NONE-) (VP to/TO (VP be/VB (ADJP-PRD cell-type/NN specific/JJ))))) ./.)
